TrialAntimicrobial agents and chemotherapy2023

Safety, Tolerability, Pharmacokinetics, and Metabolism of Telacebec (Q203) for the Treatment of Tuberculosis: a Randomized, Placebo-Controlled, Multiple Ascending Dose Phase 1B Trial.

Jeongjun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.